Treatment-resistant schizophrenia in patients with 3q29 deletion: A case series of four patients

Psychiatry Clin Neurosci. 2022 Jul;76(7):338-339. doi: 10.1111/pcn.13361. Epub 2022 May 12.

Authors

Yoshihiro Nawa^#¹, Itaru Kushima^#^{1

2}, Branko Aleksic¹, Maeri Yamamoto¹, Hiroyuki Kimura¹, Masahiro Banno^{1

3}, Ryota Hashimoto⁴, Norio Ozaki^{1

5}

Affiliations

¹ Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
² Medical Genomics Center, Nagoya University Hospital, Nagoya, Japan.
³ Department of Psychiatry, Seichiryo Hospital, Nagoya, Japan.
⁴ Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
⁵ Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan.

^# Contributed equally.

PMID: 35355370
DOI: 10.1111/pcn.13361

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Humans
Intellectual Disability*
Phenotype
Schizophrenia* / drug therapy
Schizophrenia* / genetics
Schizophrenia, Treatment-Resistant

Grants and funding